Lee Health launches drug to address pancreatic enzyme deficiency
Hyderabad: Hyderabad-based Lee Health Domain has developed a pancreatic enzyme blend derived from vegetarian source to address pancreatic exocrine insufficiency and released the drug under the brand name Enzymeact that helps in digestion of food. The people with pancreatic exocrine insufficiency find difficulty in digesting food properly due to lack of digestive enzymes, cystic fibrosis, […]
Hyderabad: Hyderabad-based Lee Health Domain has developed a pancreatic enzyme blend derived from vegetarian source to address pancreatic exocrine insufficiency and released the drug under the brand name Enzymeact that helps in digestion of food.
The people with pancreatic exocrine insufficiency find difficulty in digesting food properly due to lack of digestive enzymes, cystic fibrosis, removal of pancreas or long-term pancreatitis, said Lee Health Domain director Leela Rani.
The company’s capsule contains amylase, protease and lipase and are derived from vegetarian sources by microbial fermentation technology. Amylase aids in digestion by breaking down carbohydrates, while protease helps in digestion of dietary proteins to allow absorption of amino acids, and lipase breaks down fats in food to help better absorption in the intestine.
Vegetarian pancreatin is free of contaminants such as steroids and antibiotics. Since vegetarian pancreatin is produced through the fermentation process, it is free from solvent unlike that in animal pancreatin where solvent is required to extract the enzyme from the animal tissue.
Lee Health said the drug can be prescribed for people whose body does not make enough of their own enzymes to digest food due to pancreatic exocrine insufficiency. The capsules support in boosting the digestion process and in overcoming the deficiency of pancreatic enzymes. The drug can be administered two times a day.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
